Clinical Trials

521 enrolled 17 charts

Breast Neoplasms, Neoplasms

NCT06716073 2024-12-04

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Phase NA Recruiting

1,380 enrolled

Breast Cancer Invasive

NCT00182728 2024-10-01

NRR

Phase NA Completed

89 enrolled 10 charts

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01015625 2024-08-19

POSYTIVE

Phase NA Completed

90 enrolled 16 charts

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03493854 2024-06-26

FeDeriCa

500 enrolled 28 charts 3 FDA

Phase 2 Active not recruiting

Breast Neoplasms

NCT03982485 2024-04-30

APP

196 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT04997941 2024-04-23

MORE-T

238 enrolled

Premenopausal Breast Cancer

NCT04629846 2024-04-19

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

517 enrolled

Breast Neoplasms

NCT03272477 2024-04-17

TP-II

257 enrolled

Breast Neoplasms

NCT05809128 2024-03-25

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

Unknown

1,000 enrolled

Breast Cancer Patients

NCT02620280 2024-03-06

NeoTRIPaPDL1

278 enrolled

Phase 3 Active not recruiting

Carcinoma, Ductal, Breast, Triple Negative Breast Neoplasms

NCT03595592 2024-03-06

APTneo

650 enrolled

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Invasive Breast Cancer

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT01717131 2024-01-11

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Phase NA Active not recruiting

2,228 enrolled

Invasive Breast Cancer

NCT02636582 2023-12-05

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

43 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating

NCT06121557 2023-11-08

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1 Recruiting

24 enrolled

Breast Neoplasms

NCT05981001 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1/2 Recruiting

170 enrolled

Phase 4 Not yet recruiting

Breast Neoplasms

NCT05843292 2023-06-06

NeoSTEP

48 enrolled

Triple Negative Breast Neoplasms

NCT02586025 2023-05-22

PEONY

329 enrolled 33 charts

Breast Neoplasms

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

320 enrolled

Breast Neoplasms

NCT03578380 2023-04-18

Supermicrosurgery for Breast Cancer Survivors With Lymphedema.

Phase NA Unknown

100 enrolled

Breast Neoplasms

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Phase 1 Completed

75 enrolled 24 charts

Breast Neoplasms

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

221 enrolled 21 charts

Phase NA Active not recruiting

Breast Neoplasms

NCT02400658 2023-01-25

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

358 enrolled

Breast Neoplasms

NCT05680194 2023-01-11

EEBC

Unknown

1,000 enrolled

Breast Neoplasms

NCT04698252 2022-08-08

LARA

Phase 2 Recruiting

74 enrolled